Naevus lightening in melanoma patients under BRAF/MEK inhibitor combination therapy versus checkpoint immunotherapy: A histological and immunohistochemistry analysis

被引：2
|
作者：
Zhao, Cathy Yunjia [1 ,2 ]
Chou, Shaun [1 ,3 ]
Liu, Rose Congwei [1 ,2 ]
Fernandez-Penas, Pablo [1 ,2 ]
机构：
[1] Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia
[2] Univ Sydney, Med, Sydney, NSW, Australia
[3] Westmead Hosp, Inst Clin Pathol & Med Res, Sydney, NSW, Australia
来源：
PIGMENT CELL & MELANOMA RESEARCH | 2018年 / 31卷 / 02期
关键词：
MELANOCYTIC LESIONS;
D O I：
10.1111/pcmr.12669
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
    Homan, Morgan
    Warrier, Govind
    Lao, Christopher D.
    Yentz, Sarah
    Kraft, Shawna
    Fecher, Leslie A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [12] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Galliker, Nadja A.
    Murer, Carla
    Kamarashev, Jivko
    Dummer, Reinhard
    Goldinger, Simone M.
    EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (02) : 177 - 180
  • [13] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Nadja A. Galliker
    Carla Murer
    Jivko Kamarashev
    Reinhard Dummer
    Simone M. Goldinger
    European Journal of Dermatology, 2015, 25 : 177 - 180
  • [14] Cardiovascular monitoring in metastatic melanoma patients undergoing combination therapy with BRAF and MEK inhibitors
    Guglielmi, Giulia
    Sarocchi, Matteo
    Tini, Giacomo
    Schiavone, Arianna
    Toma, Matteo
    Spagnolo, Francesco
    Tanda, Enrica Teresa
    Boutros, Andrea
    Spallarossa, Paolo
    Porto, Italo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N20 - N21
  • [15] Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy
    Myrdal, Caitlyn N.
    Sundararajan, Srinath
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
  • [16] Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
    Francisco Meraz-Torres
    Heike Niessner
    Sarah Plöger
    Simon Riel
    Barbara Schörg
    Nicolas Casadei
    Manfred Kneilling
    Martin Schaller
    Lukas Flatz
    Boris Macek
    Thomas Eigentler
    Olaf Rieß
    Claus Garbe
    Teresa Amaral
    Tobias Sinnberg
    Journal of Experimental & Clinical Cancer Research, 43
  • [17] Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy
    Meraz-Torres, Francisco
    Niessner, Heike
    Ploeger, Sarah
    Riel, Simon
    Schoerg, Barbara
    Casadei, Nicolas
    Kneilling, Manfred
    Schaller, Martin
    Flatz, Lukas
    Macek, Boris
    Eigentler, Thomas
    Riess, Olaf
    Garbe, Claus
    Amaral, Teresa
    Sinnberg, Tobias
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [18] Acute demyelinating Polyradiculoneuropathy with CSF Pleocytosis under Therapy with BRAF/MEK Inhibitor in advanced malignant Melanoma
    Hecker, C.
    Madzar, D.
    Schultz, E.
    Debus, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 55 - 56
  • [19] First Results of an Examination of the Hearing Ability in Patients with malignant Melanoma before, under and after Therapy with Checkpoint Inhibitors or BRAF and MEK Inhibitors
    Pfoehler, C.
    Ehrmann, J.
    Saternus, R.
    Wagner, A. C.
    Yordanova, K.
    Adam, L.
    Schick, B.
    Vogt, T.
    Wenzel, G. I.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 55 - 55
  • [20] Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases
    Fujisawa, Yasuhiro
    Ito, Takamichi
    Kato, Hiroshi
    Irie, Hiroyuki
    Kaji, Tatsuya
    Maekawa, Takeo
    Asai, Jun
    Yamamoto, Yuki
    Fujimura, Taku
    Nakai, Yasuo
    Yasuda, Masahito
    Matsuyama, Kanako
    Muto, Ikko
    Matsushita, Shigeto
    Uchi, Hiroshi
    Nakamura, Yoshiyuki
    Uehara, Jiro
    Yoshino, Koji
    EUROPEAN JOURNAL OF CANCER, 2021, 145 : 210 - 220
12345